Susan Douglas, an experienced medical leader and Consultant ENT surgeon, has been appointed as the new Chief Medical Officer at Chesterfield Royal Hospital NHS Foundation Trust. She brings over 25 years of experience within the NHS to the role.
Douglas joins from The Rotherham NHS Foundation Trust, where she served as Deputy Medical Director and previously as Interim Executive Medical Director. Her leadership has focused on patient safety, clinical effectiveness, quality improvement, and strengthening the medical voice, alongside her clinical practice in Otolaryngology, Head and Neck Surgery, with a specialisation in Otology.
Originally from Jamaica, Douglas graduated with honours in medicine from the University of the West Indies. She came to the UK in 1999 on a Commonwealth Scholarship. Her career has spanned roles in Newcastle, Leicester, Derby, and Nottingham, as well as a fellowship at the Sydney Cochlear Implant Centre in Australia. She became a consultant at University Hospitals Bristol in 2008 before moving to Rotherham in 2013.
"I’m really delighted to be joining Chesterfield Royal as Chief Medical Officer," said Douglas. "What matters most to me is working alongside colleagues, listening to their experiences and creating the conditions where our clinical teams can provide the very best care for patients. I’m looking forward to getting to know #TeamCRH, building on the great work already happening here and playing my part in the Trust’s next chapter."
Dr Hal Spencer, Chief Executive at Chesterfield Royal Hospital NHS Foundation Trust, welcomed Douglas, stating: “We’re delighted to welcome Susan to Chesterfield Royal. She brings a wealth of clinical and senior leadership experience, but just as importantly, a very clear commitment to listening to colleagues, supporting our clinical teams and continually improving care for our patients. Susan’s values and approach to leadership are a great fit for #TeamCRH and I’m really looking forward to working with her as we continue to improve care together.”
Douglas succeeds Kevin Sargen, who is returning to full-time clinical practice at the Trust.
